This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
CHANGES
Dr. Vollmer named Chair at Barrow
⇓Timothy L. Vollmer, MD was recently appointed Chairman of the Division of Neurology and Chief of Neuroimmunology at the Barrow Neurological Institute. Vollmer came from Yale where he was Vice Chairman of the Department of Neurology and Director of the MS Research Center. He is extensively published and has participated in numerous clinical trials of potential new therapies for MS. He was also a part of the team that made medical history by transplanting autologous myelin-forming cells into a human brain in an attempt to repair a lesion caused by MS. “I’ve decided to come to Barrow for several reasons. It’s an excellent place to develop a clinical program, it has great potential for collaboration, and the research environment is very rich,” said Dr. Vollmer.
Timothy L. Vollmer
Drs. Kenton and Vick recognized for service to the ABPN
⇓Dr. Edgar Kenton was elected to serve as President of the American Board of Psychiatry and Neurology (ABPN) effective January 1, 2003. Dr. Kenton has been with the ABPN for 7 years and has served as Secretary of the Board. He has also served on many of the committees including the Finance Committee, the Appeals Committee, and the Subcommittee for Research and Development on Standardized Patients. Dr. Kenton is also a key liaison with the American Board of Anesthesia and the American Board of Physical Medicine and Rehabilitation (ABPMR) on issues related to both pain medicine and brain injury.
Edgar Kenton
⇓Dr. Nicholas Vick is finishing his 8th and final year of service as an ABPN Neurology Director. He continues to serve as the Vice President of the Board and as the Chair of the Neurology Council. He also serves on numerous Committees of the ABPN including Finance Committee, the Maintenance of Certification Committee, and the Nominating Committee. Dr. Vick has also facilitated successful completion of several initiatives including …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg